相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk factors for hospital-acquired pneumonia among inpatients with mental disorders in a large mental health center within a tertiary general hospital
Jingjing Han et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2023)
Antidepressants Usage and Risk of Pneumonia Among Elderly Patients With the Parkinson's Disease: A Population-Based Case-Control Study
Wei-Yin Kuo et al.
FRONTIERS IN MEDICINE (2022)
IL-6 and other biomarkers as predictors of severity in COVID-19
N. Broman et al.
ANNALS OF MEDICINE (2021)
Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a Meta-analysis
F. Gay et al.
PSYCHIATRY RESEARCH (2021)
COVID-19 Prevalence and Mortality Among Schizophrenia Patients: A Large-Scale Retrospective Cohort Study
Dana Tzur Bitan et al.
SCHIZOPHRENIA BULLETIN (2021)
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19
Katlyn Nemani et al.
JAMA PSYCHIATRY (2021)
Influencing Factors of Hospital-Acquired Pneumonia Infection in the Middle-Aged and Elderly Patients With Schizophrenia
Mi Yang et al.
FRONTIERS IN PSYCHIATRY (2021)
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Markku Lahteenvuo et al.
DRUGS (2021)
Antipsychotic polypharmacy in adult patients diagnosed with schizophrenia: A retrospective study
Bogdan Patrichi et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Polypharmacy in schizophrenia
Lone Baandrup
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2020)
Psychotropic Drug-Associated Pneumonia in Older Adults
Blair Rajamaki et al.
DRUGS & AGING (2020)
Non-ventilator health care-associated pneumonia (NV-HAP): NV-HAP Risk Factors
Michelle Vignari
AMERICAN JOURNAL OF INFECTION CONTROL (2020)
Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia A case report
Jun Zhao et al.
MEDICINE (2020)
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia
George A. Keepers et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Hospital-acquired and ventilator-associated pneumonia: Diagnosis, management, and prevention
Anita Rae Modi et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2020)
Antipsychotic prescription and polypharmacy among outpatients with schizophrenia in a Nigerian hospital
Ihechiluru Goodnews Anozie et al.
NIGERIAN POSTGRADUATE MEDICAL JOURNAL (2020)
Predicting hospital-acquired pneumonia among schizophrenic patients: a machine learning approach
Kuang Ming Kuo et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2019)
Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study
Heidi Taipale et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults
Giuseppe Cicala et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
ECT in schizophrenia: a review of the evidence
Sandeep Grover et al.
ACTA NEUROPSYCHIATRICA (2019)
Benzodiazepines or related drugs and risk of pneumonia: A systematic review and meta-analysis
Guo-qing Sun et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses
Hadar Zaman et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
The epidemiology of nonventilator hospital-acquired pneumonia in the United States
Karen K. Giuliano et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2018)
Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review
Antoine Yrondi et al.
BRAIN STIMULATION (2018)
Serotonergic antidepressant use and morbidity and mortality among older adults with COPD
Nicholas T. Vozoris et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Benzodiazepines and risk of pneumonia in schizophrenia: a nationwide case-control study
Sheng-Yun Cheng et al.
PSYCHOPHARMACOLOGY (2018)
Antipsychotic drug use and pneumonia: Systematic review and meta-analysis
O. Dzahini et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia - a short version for primary care
Alkomiet Hasan et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2017)
Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia Systematic Overview and Quality Appraisal of the Meta-analytic Evidence
Christoph U. Correll et al.
JAMA PSYCHIATRY (2017)
Guidelines for the Pharmacotherapy of Schizophrenia in Adults
Gary Remington et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2017)
Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease
Heidi Taipale et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2017)
Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis
Bartosz Helfer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case-Control Study
Satabdi Chatterjee et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2016)
The balance between the serum levels of IL-6 and IL-10 cytokines discriminates mild and severe acute pneumonia
Rita de Cassia Coelho Moraes de Brito et al.
BMC PULMONARY MEDICINE (2016)
Augmentation with antidepressants in schizophrenia treatment: benefit or risk
Ye-Meng Mao et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2015)
The Immune System and Electroconvulsive Therapy for Depression
Sinan Guloksuz et al.
JOURNAL OF ECT (2014)
Benzodiazepine Augmented γ-Amino-Butyric Acid Signaling Increases Mortality From Pneumonia in Mice
Robert D. Sanders et al.
CRITICAL CARE MEDICINE (2013)
Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: A meta-analysis and cochrane review of randomized controlled trials
Markus Dold et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Antipsychotic Drugs, Mood Stabilizers, and Risk of Pneumonia in Bipolar Disorder: A Nationwide Case-Control Study
Shu-Yu Yang et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia
Chian-Jue Kuo et al.
SCHIZOPHRENIA BULLETIN (2013)
Indications for electroconvulsive treatment in schizophrenia: A systematic review
Maurizio Pompili et al.
SCHIZOPHRENIA RESEARCH (2013)
The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort
Usman Iqbal et al.
THORAX (2013)
Pramipexole use and the risk of pneumonia
Pierre Ernst et al.
BMC NEUROLOGY (2012)
Benzodiazepines for schizophrenia (Review)
Markus Dold et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Factors associated with inflammatory cytokine patterns in community-acquired pneumonia
R. Martinez et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Use of Opioids or Benzodiazepines and Risk of Pneumonia in Older Adults: A Population-Based Case-Control Study
Sascha Dublin et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
The cognitive impact of antiepileptic drugs
Clare M. Eddy et al.
Therapeutic Advances in Neurological Disorders (2011)
Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures
Sean Hennessy et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Side effects of antidepressants: An overview
EA Khawam et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2006)
Antiepileptic drugs in schizophrenia:: a review
L Hosák et al.
EUROPEAN PSYCHIATRY (2002)
分享论文
